Wockhardt Share Price | This new antibiotic combination marks a significant advancement in the battle against multidrug-resistant infections, particularly those that are resistant to current…
HCL Tech Q3 Results Live Updates: The IT giant will post its results for the December ended 2024 quarter today. A key factor to watch…
This will also be the first instance since RVNL’s listing that the stock would have declined for five months in a row.
The Founder and Chief Investment Officer of Shikhara Investment likes IT, pharma, and healthcare sectors, and has reduced exposure to costly domestic cyclical stocks.
IREDA had approved raising funds to the tune of ₹4,500 crore last year, and the government is likely to dilute up to 7% stake of…
All 10 analysts who have coverage on Piramal Pharma, have a “buy” rating on the stock. JM Financial has the highest price target on the…
Brokerage firm Kotak Institutional Equities has cut its price target to ₹1,330 from ₹1,475 earlier, while Ambit has a target of ₹1,037 on the stock.
IREDA had approved raising funds to the tune of ₹4,500 crore last year, and the government is likely to dilute up to 7% stake of…
With valuations nearing all-time highs, BSE’s pricing appears aligned with global peers, leaving the risk-reward outlook largely balanced, the brokerage said.
Last week, brokerage firm Goldman Sachs had downgraded IndusInd Bank’s shares to “neutral” from its earlier rating of “buy” and also cut its price target…